Benralizumab Clinical Trials
3 recruitingDrug
Phase 32Phase 41
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Eosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilia Syndrome (HES)
AstraZeneca14 enrolled15 locationsNCT06512883
Recruiting
Phase 3
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
Asthma
AstraZeneca200 enrolled116 locationsNCT05692180
Recruiting
Phase 4
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
Moderate to Severe Asthma
University of California, San Diego120 enrolled3 locationsNCT06385236